Cargando…
A multi-center trial on efficacy and safety of the LifeTech CeraFlex(TM) ASD occluder for transcatheter closure in patients with secundum atrial septal defects
BACKGROUND: The last decades have brought remarkable improvements in treatment strategy and occluder modification of secundum atrial septal defect (ASD) closure. Approval, efficacy and safety of ASD closure devices have previously been demonstrated. This study investigated the clinical efficacy and...
Autores principales: | Fritz, Celina, Engelhardt, Andrea, Grohmann, Jochen, Dähnert, Ingo, Hummel, Johanna, Tanase, Daniel, Ewert, Peter, Eicken, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412214/ https://www.ncbi.nlm.nih.gov/pubmed/36033225 http://dx.doi.org/10.21037/cdt-21-798 |
Ejemplares similares
-
Experience in patent foramen ovale closure with the CERA Lifetech occluder in patients with cryptogenic stroke
por: Węglarz, Przemysław, et al.
Publicado: (2023) -
Late Presentation of Persistent Left Superior Caval Vein in a Univentricular Heart with Successful Transcutaneous Occlusion Using Cera Lifetech Atrial Septal Occluder
por: AL-Ammouri, Iyad, et al.
Publicado: (2014) -
Safety of Occlutech Septal Occluder ACCELL Flex II for Transcatheter Closure of Secundum Atrial Septal Defects in Children: A Long-Term Follow-Up
por: El-Sisi, Amal M., et al.
Publicado: (2022) -
Importance of anatomic variations in secundum ASD: residual ASD detected on postoperative 31st year
por: Yetkin, Ufuk, et al.
Publicado: (2015) -
Transcatheter closure of left ventricle to right atrial communication using cera duct occluder
por: Ganesan, Gnanavelu, et al.
Publicado: (2017)